Zerun HPV-9
/ Walvax
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
October 14, 2022
Phase III Clinical Trial Comparing the Immunogenicity of 9-valent HPV Recombinant Vaccine and Gardasil-9
(clinicaltrials.gov)
- P3 | N=1200 | Active, not recruiting | Sponsor: Shanghai Zerun Biotechnology Co.,Ltd
New P3 trial • Cervical Cancer • Infectious Disease • Oncology • Solid Tumor
1 to 1
Of
1
Go to page
1